Abbott Laboratories (ABT) Change in Cash (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Change in Cash data on file, last reported at -$1.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 58.58% year-over-year to -$1.7 billion; the trailing twelve-month figure through Mar 2026 stood at $271.0 million (up 9.27% YoY), and the FY2025 full-year result was $906.0 million, up 25.83% from the prior year.
• Change in Cash declined to -$1.7 billion in Q1 2026, from $1.0 billion in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $1.3 billion in Q2 2022 to a low of -$2.1 billion in Q1 2022.
• A 5-year average of -$176.2 million and a median of $187.0 million in 2023 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash plunged 274.67% in 2022 and soared 1643.1% in 2025, its largest moves.
• Tracing ABT's Change in Cash over 5 years: stood at $288.0 million in 2022, then slumped by 35.07% to $187.0 million in 2023, then plunged by 68.98% to $58.0 million in 2024, then soared by 1643.1% to $1.0 billion in 2025, then sank by 270.03% to -$1.7 billion in 2026.
• Business Quant data shows ABT's Change in Cash at -$1.7 billion in Q1 2026, $1.0 billion in Q4 2025, and $560.0 million in Q3 2025.